Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP674771.RAO3UtwU9MkOs02HfSB38mVy2DP3_XIbHi9Lr425yh-z8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP674771.RAO3UtwU9MkOs02HfSB38mVy2DP3_XIbHi9Lr425yh-z8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP674771.RAO3UtwU9MkOs02HfSB38mVy2DP3_XIbHi9Lr425yh-z8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP674771.RAO3UtwU9MkOs02HfSB38mVy2DP3_XIbHi9Lr425yh-z8130_provenance.
- NP674771.RAO3UtwU9MkOs02HfSB38mVy2DP3_XIbHi9Lr425yh-z8130_assertion description "[As a result of molecularly targeted anti-EGFR therapies (cetuximab and panitumumab) complementing chemotherapy, liver metastases can reduce in size and become operable in certain patients, which can contribute to the complete recovery of the patient.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674771.RAO3UtwU9MkOs02HfSB38mVy2DP3_XIbHi9Lr425yh-z8130_provenance.
- NP674771.RAO3UtwU9MkOs02HfSB38mVy2DP3_XIbHi9Lr425yh-z8130_assertion evidence source_evidence_literature NP674771.RAO3UtwU9MkOs02HfSB38mVy2DP3_XIbHi9Lr425yh-z8130_provenance.
- NP674771.RAO3UtwU9MkOs02HfSB38mVy2DP3_XIbHi9Lr425yh-z8130_assertion SIO_000772 21163770 NP674771.RAO3UtwU9MkOs02HfSB38mVy2DP3_XIbHi9Lr425yh-z8130_provenance.
- NP674771.RAO3UtwU9MkOs02HfSB38mVy2DP3_XIbHi9Lr425yh-z8130_assertion wasDerivedFrom befree-20140225 NP674771.RAO3UtwU9MkOs02HfSB38mVy2DP3_XIbHi9Lr425yh-z8130_provenance.
- NP674771.RAO3UtwU9MkOs02HfSB38mVy2DP3_XIbHi9Lr425yh-z8130_assertion wasGeneratedBy ECO_0000203 NP674771.RAO3UtwU9MkOs02HfSB38mVy2DP3_XIbHi9Lr425yh-z8130_provenance.
- befree-20140225 importedOn "2014-02-25" NP674771.RAO3UtwU9MkOs02HfSB38mVy2DP3_XIbHi9Lr425yh-z8130_provenance.